David C. Klorig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David C. Klorig has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Dwayne W. Godwin
Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA
4 shared publications - Gregory E. Alberto
Wake Forest School of Medicine; Department of Neurobiology and Anatomy, Winston-Salem, USA
3 shared publications - Jennifer R. Stapleton-Kotloski
Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA
2 shared publications T. Smith
Department of Neurobiology and Anatomy
2 shared publicationsAllison T. Goldstein
Department of Neurobiology and Anatomy Wake Forest University School of Medicine North Carolina Winston‐Salem USA
1 shared publication- Anthony Atala
Wake Forest Institute for Regenerative Medicine, Wake Forest University Health Sciences, North Carolina, USA
1 shared publication
Latest Publications
- Open Access
- 13 May 2024
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 48 (7) , 1278-1288
Protein kinase C epsilon‐mediated modulation of T‐type calcium channels underlies alcohol withdrawal hyperexcitability in the midline thalamus
Background: Millions of people struggle with alcohol use disorder (AUD). Abrupt abstinence after a period of chronic alcohol use can precipitate the alcohol withdrawal syndrome (AWS), which includes hyperexcitability and, potentially, seizures. We have shown that T‐type Ca2+ channels are novel, sensitive targets of alcohol, an effect that is dependent upon protein kinase C (PKC). The purpose of this study was to (1) understand midline thalamic neuronal hyperexcitability during alcohol withdrawal and its dependence on PKC; (2) characterize T channel functional changes using both current clamp and voltage clamp methods; and (3) determine which PKC isoform may be responsible for alcohol withdrawal (WD) effects.Methods: Whole‐cell patch clamp recordings were performed in midline thalamic neurons in brain slices prepared from C57bl/6 mice that underwent chronic intermittent alcohol exposure in a standard vapor chamber model. The recordings were compared to those from air‐exposed controls. T‐channel inactivation curves and burst responses were acquired through voltage‐clamp and current‐clamp recordings, respectively.Results: Whole‐cell voltage clamp recordings of native T‐type current exhibited a depolarizing shift in the voltage‐dependency of inactivation during alcohol withdrawal compared to air‐exposed controls. A PKCε translocation inhibitor peptide mitigated this change. Current clamp recordings demonstrated more spikes per burst during alcohol withdrawal. Consistent with voltage clamp findings, the PKCɛ translocation inhibitor peptide reduced the number of spikes per burst after WD.Conclusion: We found that alcohol WD produces T channel‐mediated hyperexcitability in the midline thalamus, produced in part by a shift in the inactivation curve consistent with greater availability of T current. WD effects on T current inactivation were reduced to control levels by blocking PKCε translocation. Our results demonstrate that PKCε translocation plays an important role in the regulation of alcohol withdrawal‐induced hyperexcitability in midline thalamic circuitry.
- 13 May 2024
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 48 (7) , 1278-1288
Open AccessProtein kinase C epsilon‐mediated modulation of T‐type calcium channels underlies alcohol withdrawal hyperexcitability in the midline thalamus
Background: Millions of people struggle with alcohol use disorder (AUD). Abrupt abstinence after a period of chronic alcohol use can precipitate the alcohol withdrawal syndrome (AWS), which includes hyperexcitability and, potentially, seizures. We have shown that T‐type Ca2+ channels are novel, sensitive targets of alcohol, an effect that is dependent upon protein kinase C (PKC). The purpose of this study was to (1) understand midline thalamic neuronal hyperexcitability during alcohol withdrawal and its dependence on PKC; (2) characterize T channel functional changes using both current clamp and voltage clamp methods; and (3) determine which PKC isoform may be responsible for alcohol withdrawal (WD) effects.Methods: Whole‐cell patch clamp recordings were performed in midline thalamic neurons in brain slices prepared from C57bl/6 mice that underwent chronic intermittent alcohol exposure in a standard vapor chamber model. The recordings were compared to those from air‐exposed controls. T‐channel inactivation curves and burst responses were acquired through voltage‐clamp and current‐clamp recordings, respectively.Results: Whole‐cell voltage clamp recordings of native T‐type current exhibited a depolarizing shift in the voltage‐dependency of inactivation during alcohol withdrawal compared to air‐exposed controls. A PKCε translocation inhibitor peptide mitigated this change. Current clamp recordings demonstrated more spikes per burst during alcohol withdrawal. Consistent with voltage clamp findings, the PKCɛ translocation inhibitor peptide reduced the number of spikes per burst after WD.Conclusion: We found that alcohol WD produces T channel‐mediated hyperexcitability in the midline thalamus, produced in part by a shift in the inactivation curve consistent with greater availability of T current. WD effects on T current inactivation were reduced to control levels by blocking PKCε translocation. Our results demonstrate that PKCε translocation plays an important role in the regulation of alcohol withdrawal‐induced hyperexcitability in midline thalamic circuitry.
- Open Access
- 4 January 2023
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 47 (2) , 211-218
Alcohol withdrawal produces changes in excitability, population discharge probability, and seizure threshold
Background: Alcohol withdrawal syndrome (AWS) results from the sudden cessation of chronic alcohol use and is associated with high morbidity and mortality. Alcohol withdrawal‐induced central nervous system (CNS) hyperexcitability results from complex, compensatory changes in synaptic efficacy and intrinsic excitability. These changes in excitability counteract the depressing effects of chronic ethanol on neural transmission and underlie symptoms of AWS, which range from mild anxiety to seizures and death. The development of targeted pharmacotherapies for treating AWS has been slow, due in part to the lack of available animal models that capture the key features of human AWS. Using a unique optogenetic method of probing network excitability, we examined electrophysiologic correlates of hyperexcitability sensitive to early changes in CNS excitability. This method is sensitive to pharmacologic treatments that reduce excitability and may represent a platform for AWS drug development.Methods: We applied a newly developed method, the optogenetic population discharge threshold (oPDT), which uses light intensity response curves to measure network excitability in chronically implanted mice. Excitability was tracked using the oPDT before, during, and after the chronic intermittent exposure (CIE) model of alcohol withdrawal (WD).Results: Alcohol withdrawal produced a dose‐dependent leftward shift in the oPDT curve (denoting increased excitability), which was detectable in as few as three exposure cycles. This shift in excitability mirrored an increase in the number of spontaneous interictal spikes during withdrawal. In addition, Withdrawal lowered seizure thresholds and increased seizure severity in optogenetically kindled mice.Conclusion: We demonstrate that the oPDT provides a sensitive measure of alcohol withdrawal‐induced hyperexcitability. The ability to actively probe the progression of excitability without eliciting potentially confounding seizures promises to be a useful tool in the preclinical development of next‐generation pharmacotherapies for AWS.
- 4 January 2023
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 47 (2) , 211-218
Open AccessAlcohol withdrawal produces changes in excitability, population discharge probability, and seizure threshold
Background: Alcohol withdrawal syndrome (AWS) results from the sudden cessation of chronic alcohol use and is associated with high morbidity and mortality. Alcohol withdrawal‐induced central nervous system (CNS) hyperexcitability results from complex, compensatory changes in synaptic efficacy and intrinsic excitability. These changes in excitability counteract the depressing effects of chronic ethanol on neural transmission and underlie symptoms of AWS, which range from mild anxiety to seizures and death. The development of targeted pharmacotherapies for treating AWS has been slow, due in part to the lack of available animal models that capture the key features of human AWS. Using a unique optogenetic method of probing network excitability, we examined electrophysiologic correlates of hyperexcitability sensitive to early changes in CNS excitability. This method is sensitive to pharmacologic treatments that reduce excitability and may represent a platform for AWS drug development.Methods: We applied a newly developed method, the optogenetic population discharge threshold (oPDT), which uses light intensity response curves to measure network excitability in chronically implanted mice. Excitability was tracked using the oPDT before, during, and after the chronic intermittent exposure (CIE) model of alcohol withdrawal (WD).Results: Alcohol withdrawal produced a dose‐dependent leftward shift in the oPDT curve (denoting increased excitability), which was detectable in as few as three exposure cycles. This shift in excitability mirrored an increase in the number of spontaneous interictal spikes during withdrawal. In addition, Withdrawal lowered seizure thresholds and increased seizure severity in optogenetically kindled mice.Conclusion: We demonstrate that the oPDT provides a sensitive measure of alcohol withdrawal‐induced hyperexcitability. The ability to actively probe the progression of excitability without eliciting potentially confounding seizures promises to be a useful tool in the preclinical development of next‐generation pharmacotherapies for AWS.
- Open Access
- 6 September 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-13
MEG source imaging detects optogenetically-induced activity in cortical and subcortical networks
Magnetoencephalography measures neuromagnetic activity with high temporal, and theoretically, high spatial resolution. We developed an experimental platform combining MEG-compatible optogenetic techniques in nonhuman primates for use as a functional brain-mapping platform. Here we show localization of optogenetically evoked signals to known sources in the superficial arcuate sulcus of cortex and in CA3 of hippocampus at a resolution of 750 µm3. We detect activation in subcortical, thalamic, and extended temporal structures, conforming to known anatomical and functional brain networks associated with the respective sites of stimulation. This demonstrates that high-resolution localization of experimentally produced deep sources is possible within an intact brain. This approach is suitable for exploring causal relationships between discrete brain regions through precise optogenetic control and simultaneous whole brain MEG recording with high-resolution magnetic source imaging (MSI).
- 6 September 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-13
Open AccessMEG source imaging detects optogenetically-induced activity in cortical and subcortical networks
Magnetoencephalography measures neuromagnetic activity with high temporal, and theoretically, high spatial resolution. We developed an experimental platform combining MEG-compatible optogenetic techniques in nonhuman primates for use as a functional brain-mapping platform. Here we show localization of optogenetically evoked signals to known sources in the superficial arcuate sulcus of cortex and in CA3 of hippocampus at a resolution of 750 µm3. We detect activation in subcortical, thalamic, and extended temporal structures, conforming to known anatomical and functional brain networks associated with the respective sites of stimulation. This demonstrates that high-resolution localization of experimentally produced deep sources is possible within an intact brain. This approach is suitable for exploring causal relationships between discrete brain regions through precise optogenetic control and simultaneous whole brain MEG recording with high-resolution magnetic source imaging (MSI).
- Open Access
Optogenetic activation of nonhuman primate cortical and subcortical brain circuits highlights detection capabilities of MEG source imaging
Magnetoencephalography (MEG) measures neuromagnetic activity with high temporal, and theoretically, high spatial resolution. However, the ability of magnetic source imaging (MSI) to localize deep sources is uncertain. We developed an experimental platform combining MEG-compatible optogenetic techniques in non-human primates (NHPs) to test the ability of MEG/MSI to image deep signals. We demonstrate localization of optogenetically-evoked signals to known sources in the superficial arcuate sulcus of cortex and in CA3 of hippocampus at a resolution of 750 µm 3 . In response to stimulation of arcuate sulcus and hippocampus, we detected activation in subcortical and thalamic structures, or extended temporal networks, respectively. This is the first demonstration of accurate localization of deep sources within an intact brain using a novel combination of optogenetics with MEG/MSI. This approach is suitable for exploring causal relationships between discrete brain regions through precise optogenetic control and simultaneous whole brain recording.
Open AccessOptogenetic activation of nonhuman primate cortical and subcortical brain circuits highlights detection capabilities of MEG source imaging
Magnetoencephalography (MEG) measures neuromagnetic activity with high temporal, and theoretically, high spatial resolution. However, the ability of magnetic source imaging (MSI) to localize deep sources is uncertain. We developed an experimental platform combining MEG-compatible optogenetic techniques in non-human primates (NHPs) to test the ability of MEG/MSI to image deep signals. We demonstrate localization of optogenetically-evoked signals to known sources in the superficial arcuate sulcus of cortex and in CA3 of hippocampus at a resolution of 750 µm 3 . In response to stimulation of arcuate sulcus and hippocampus, we detected activation in subcortical and thalamic structures, or extended temporal networks, respectively. This is the first demonstration of accurate localization of deep sources within an intact brain using a novel combination of optogenetics with MEG/MSI. This approach is suitable for exploring causal relationships between discrete brain regions through precise optogenetic control and simultaneous whole brain recording.
- Open Access
- 16 October 2019
- Published by Society for Neuroscience in eneuro
- Vol. 6 (6)
Optogenetically-Induced Population Discharge Threshold as a Sensitive Measure of Network Excitability
Network excitability is governed by synaptic efficacy, intrinsic excitability, and the circuitry in which these factors are expressed. The complex interplay between these factors determines how circuits function and, at the extreme, their susceptibility to seizure. We have developed a sensitive, quantitative estimate of network excitability in freely behaving mice using a novel optogenetic intensity-response procedure. Synchronous activation of deep sublayer CA1 pyramidal cells produces abnormal network-wide epileptiform population discharges (PD) that are nearly indistinguishable from spontaneously-occurring interictal spikes. By systematically varying light intensity, and therefore the magnitude of the optogenetically-mediated current, we generated intensity-response curves using the probability of PD as the dependent variable. Manipulations known to increase excitability, such as sub-convulsive doses (20 mg/kg) of the chemoconvulsant pentylenetetrazol (PTZ), produced a leftward shift in the curve compared to baseline. The anti-epileptic drug levetiracetam (40 mk/kg), in combination with PTZ, produced a rightward shift. Optogenetically-induced population discharge threshold (oPDT) baselines were stable over time, suggesting the metric is appropriate for within-subject experimental designs with multiple pharmacological manipulations. Significance Statement Abnormal excitability is associated with a number of neurological disorders, including epilepsy. Excitability can be measured in single cells in vitro, but it is difficult to extrapolate from these values to the functional impact on the associated network. Epileptiform population discharges are network-wide events that represent a distinct transition from normal to abnormal functional modes. We developed a new method that uses light intensity-response curves to precisely determine the threshold for this transition as a surrogate measure of network excitability.
- 16 October 2019
- Published by Society for Neuroscience in eneuro
- Vol. 6 (6)
Open AccessOptogenetically-Induced Population Discharge Threshold as a Sensitive Measure of Network Excitability
Network excitability is governed by synaptic efficacy, intrinsic excitability, and the circuitry in which these factors are expressed. The complex interplay between these factors determines how circuits function and, at the extreme, their susceptibility to seizure. We have developed a sensitive, quantitative estimate of network excitability in freely behaving mice using a novel optogenetic intensity-response procedure. Synchronous activation of deep sublayer CA1 pyramidal cells produces abnormal network-wide epileptiform population discharges (PD) that are nearly indistinguishable from spontaneously-occurring interictal spikes. By systematically varying light intensity, and therefore the magnitude of the optogenetically-mediated current, we generated intensity-response curves using the probability of PD as the dependent variable. Manipulations known to increase excitability, such as sub-convulsive doses (20 mg/kg) of the chemoconvulsant pentylenetetrazol (PTZ), produced a leftward shift in the curve compared to baseline. The anti-epileptic drug levetiracetam (40 mk/kg), in combination with PTZ, produced a rightward shift. Optogenetically-induced population discharge threshold (oPDT) baselines were stable over time, suggesting the metric is appropriate for within-subject experimental designs with multiple pharmacological manipulations. Significance Statement Abnormal excitability is associated with a number of neurological disorders, including epilepsy. Excitability can be measured in single cells in vitro, but it is difficult to extrapolate from these values to the functional impact on the associated network. Epileptiform population discharges are network-wide events that represent a distinct transition from normal to abnormal functional modes. We developed a new method that uses light intensity-response curves to precisely determine the threshold for this transition as a surrogate measure of network excitability.
- Open Access
Optogenetically-Induced Population Discharge Threshold as a Sensitive Measure of Network Excitability
Network excitability is governed by synaptic efficacy, intrinsic excitability, and the circuitry in which these factors are expressed. The complex interplay between these factors determines how circuits function, and at the extreme, their susceptibility to seizure. We have developed a novel optogenetic intensity response procedure that provides a sensitive, quantitative estimate of network excitability. By combining optogenetic stimulation of the hippocampus with chronic multi-site recordings in peri-hippocampal structures of awake behaving mice, we induced abnormal network-wide epileptiform population discharges (PD) that were nearly indistinguishable from spontaneously occurring interictal spikes. By systematically varying light intensity, and therefore the magnitude of the optogenetically-mediated current, we generated intensity-response curves using the probability of PD as the dependent variable. This probability curve was well fit by a Boltzmann function, from which we calculated the intensity that produces a half-maximal probability of discharge (I50). This novel metric, the I50, is correlated with the optogenetic after-discharge threshold (oADT) in the same mice. Manipulations known to increase excitability, such as sub-convulsive doses (20 mg/kg) of the chemoconvulsant pentylenetetrazol (PTZ), produced a leftward shift in the curve compared to baseline. The anti-epileptic drug levetiracetam (40 mk/kg), in combination with PTZ, produced a rightward shift. Optogenetically-induced population discharge threshold (oPDT) baselines were stable over time, suggesting the metric is appropriate for within-subject experimental designs with multiple pharmacological manipulations. The oPDT is a sensitive measure of subconvulsive network excitability, with broad applicability to a number of areas of investigation. Significance Statement: Network excitability is carefully regulated by homeostatic mechanisms in the brain in order to maintain optimal functional conditions. Abnormal excitability is associated with a number of neurological disorders including epilepsy. Excitability can be measured in single cells in vitro , but it is difficult to extrapolate from these values to the functional impact on the network as a whole. Epileptiform discharges are network wide events that represent a distinct transition from normal to abnormal functional modes. We developed a new technique that uses light intensity-response curves to precisely determine the threshold for this transition as a surrogate measure of network excitability and seizure susceptibility.
Open AccessOptogenetically-Induced Population Discharge Threshold as a Sensitive Measure of Network Excitability
Network excitability is governed by synaptic efficacy, intrinsic excitability, and the circuitry in which these factors are expressed. The complex interplay between these factors determines how circuits function, and at the extreme, their susceptibility to seizure. We have developed a novel optogenetic intensity response procedure that provides a sensitive, quantitative estimate of network excitability. By combining optogenetic stimulation of the hippocampus with chronic multi-site recordings in peri-hippocampal structures of awake behaving mice, we induced abnormal network-wide epileptiform population discharges (PD) that were nearly indistinguishable from spontaneously occurring interictal spikes. By systematically varying light intensity, and therefore the magnitude of the optogenetically-mediated current, we generated intensity-response curves using the probability of PD as the dependent variable. This probability curve was well fit by a Boltzmann function, from which we calculated the intensity that produces a half-maximal probability of discharge (I50). This novel metric, the I50, is correlated with the optogenetic after-discharge threshold (oADT) in the same mice. Manipulations known to increase excitability, such as sub-convulsive doses (20 mg/kg) of the chemoconvulsant pentylenetetrazol (PTZ), produced a leftward shift in the curve compared to baseline. The anti-epileptic drug levetiracetam (40 mk/kg), in combination with PTZ, produced a rightward shift. Optogenetically-induced population discharge threshold (oPDT) baselines were stable over time, suggesting the metric is appropriate for within-subject experimental designs with multiple pharmacological manipulations. The oPDT is a sensitive measure of subconvulsive network excitability, with broad applicability to a number of areas of investigation. Significance Statement: Network excitability is carefully regulated by homeostatic mechanisms in the brain in order to maintain optimal functional conditions. Abnormal excitability is associated with a number of neurological disorders including epilepsy. Excitability can be measured in single cells in vitro , but it is difficult to extrapolate from these values to the functional impact on the network as a whole. Epileptiform discharges are network wide events that represent a distinct transition from normal to abnormal functional modes. We developed a new technique that uses light intensity-response curves to precisely determine the threshold for this transition as a surrogate measure of network excitability and seizure susceptibility.
- 5 March 2014
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 227, 132-139
A magnetic rotary optical fiber connector for optogenetic experiments in freely moving animals
- 5 March 2014
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 227, 132-139
A magnetic rotary optical fiber connector for optogenetic experiments in freely moving animals
- Top Cited Papers
- 1 January 2008
- Published by Elsevier in Biomaterials
- Vol. 29 (1) , 118-128
The use of keratin biomaterials derived from human hair for the promotion of rapid regeneration of peripheral nerves
- 1 January 2008
- Published by Elsevier in Biomaterials
- Vol. 29 (1) , 118-128
Top Cited PapersThe use of keratin biomaterials derived from human hair for the promotion of rapid regeneration of peripheral nerves
- 30 September 2006
- Published by Elsevier in NeuroToxicology
- Vol. 27 (5) , 826-834
Potentiating effect of the ATP-sensitive potassium channel blocker glibenclamide on complex I inhibitor neurotoxicity in vitro and in vivo
- 30 September 2006
- Published by Elsevier in NeuroToxicology
- Vol. 27 (5) , 826-834
Potentiating effect of the ATP-sensitive potassium channel blocker glibenclamide on complex I inhibitor neurotoxicity in vitro and in vivo